Sep. 13 at 4:39 PM
$ANVS Post 2 of …
@cheesedonkey:
Andy, I think that honest and reflective investors owe @CC_Abbott more a just an apology. I think we should support her published works. It is a common tendency for investors to loose objectivity once they make an investment.
CC_Abbott’s work, along with others shouldn’t be threatening to investors. It should provide balance. This includes an investor’s ability to re-evaluate their investment decision, weighting it for better performance and more importantly, for capital preservation.
Dr. Maria Maccecchini is lying when she states she has “no clue why” CC hates her guts. Dr. Maccecchini is threatened by the truth. She has taken external and internal initiatives. This is not conjecture on my part as Dr. Maccecchini outlined this via email to me along with another Annovis Bio executive.
The National Institute on Aging (NIA) is currently supporting 495 active clinical trials on Alzheimer’s disease and related dementias (AD/ADRD) ¹.
Yet, Dr. Maccecchini promotes her herself as the one true holder of a magic drug for Alzheimer’s patients above ALL others with her statement, “At this point our drug looks more promising than any Alzheimer drug on the market or in development” ².
Dr. Maccecchini’s repeatedly states is that her drug, her trial study designs, her leadership, (her BoD, her SAB?), … are better than
$AVXL and
$CGTX and
$BIVI and, of course
$SAVA. IMO, her drug trials are "designed" to be grey intentionally so that she can perpetuate this cause for her own benefit.
Curiously, to me are Annovis Bio investors who attack Cassava Sciences as a scam. Yes, the SEC penalized SAVA
$40M along with two former executives — founder Remi Barbier (
$175,000 fine) and former SVP Lindsay Burns (
$85,000 fine) ³.
However, ANVS is NOT what investors assume it is. ANVS is potentially as harmful to investors and patients as SAVA, if not more so.
Andy, your Stocktwits account currently displays “2310 Results” for “
$ANVS from @chessedonkey”.
This count does not include replies. I would encourage you and others to do more with the information that I have been providing over the last 24 hours than “just go back to doing [my] own thing until Maria can actually keep a promise”. She make promises she NEVER intends to fulfill.
Please actively participate on this channel again and hold Dr. Maccecchini to her word. Additionally, I know that you had a falling out with @papatrick who was also heavily invested in Annovis Bio previously and suffered substantial loses. You didn’t like the negative tone of papa’s comments, but he knows a lot about this company.
Maria is very likely a crook (which is based on contemporaneous notes I have taken on a telephone calls she made to me, along with the many other interactions via email, video conference, and other communication platform that I have interacted with her and her associates on.)
But, why should investors believe me? Aren’t they better off believing in the CEO who has fired all of her CFOs instead???
I think the evidence is heavy even given how little I am able to disclose. A majority of the current ANVS investors have chosen to discredit me instead of protecting prospective investors from being lured in by Dr. Maccecchini’s false claims of drug efficacy for their loved ones.
I hope that you, Andy, aren’t among that cluster of “investors” who have chosen to take that path.
Sincerely, Tessa
Footnotes:
¹ https://www.nia.nih.gov/research/ongoing-AD-trials
² https://stocktwits.com/MaccM/message/606412928
³ https://www.sec.gov/newsroom/press-releases/2024-151#:~:text=Without%20admitting%20or%20denying%20the%20allegations%2C%20Cassava%2C,of%20
$40%20million%2C%20
$175%2C000%2C%20and%20
$85%2C000%2C%20respectively.
#CFODive #MauraWebberSadovi #StatNews #AdamFeuerstein #StephenSedgwickCNBC #ENDALZ #FDA_Drug_Info #NIH #NIA #SEC
